Get the Stockscreener App
5.44
0.00%
0.00
After Hours:
5.46
0.02
+0.37%
Rezolute Inc stock is traded at $5.44, with a volume of 306.75K.
It is up +0.00% in the last 24 hours and up +10.34% over the past month.
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
See More
Previous Close:
$5.44
Open:
$5.65
24h Volume:
306.75K
Relative Volume:
0.84
Market Cap:
$304.25M
Revenue:
-
Net Income/Loss:
$-56.83M
P/E Ratio:
-5.44
EPS:
-1
Net Cash Flow:
$-53.00M
1W Performance:
-4.23%
1M Performance:
+10.34%
6M Performance:
+64.35%
1Y Performance:
+444.00%
1-Day Range:
$5.39
$5.65
1-Week Range:
$5.2261
$5.70
52-Week Range:
$0.72
$6.0999
Rezolute Inc Stock (RZLT) Company Profile
Name
Rezolute Inc
Sector
Industry
Phone
650-206-4507
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-22 | Resumed | Canaccord Genuity | Buy |
| Jun-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-08-21 | Initiated | ROTH Capital | Buy |
| May-27-21 | Initiated | Oppenheimer | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
Rezolute Inc Stock (RZLT) Latest News
Rezolute to Participate in Upcoming Investor Conferences - The Manila Times
Rezolute (NASDAQ:RZLT) Given Outperform Rating at Wedbush - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Average Price Target from Brokerages - MarketBeat
(RZLT) Technical Pivots with Risk Controls - Stock Traders Daily
SEC Form DEFA14A filed by Rezolute Inc. - Quantisnow
AAO 2024: Rezolute’s RZ-402 shows promising Phase IIa results in DME patients - Yahoo Finance
With 62% ownership, Rezolute, Inc. (NASDAQ:RZLT) boasts of strong institutional backing - Yahoo Finance
Cubist Systematic Strategies LLC Boosts Stock Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit - StockTitan
Renaissance Technologies LLC Sells 149,660 Shares of Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Shares Acquired by Cubist Systematic Strategies LLC - Defense World
Marshall Wace LLP Invests $4.50 Million in Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Continuing Rare Disease Treatment With A Compassionate Use Program (CUP) - Clinical Leader
Nantahala Capital Management LLC Cuts Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
XTX Topco Ltd Has $145,000 Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute's SWOT analysis: biotech firm's stock poised for growth amid clinical trials - Investing.com
Rezolute, Inc. (NASDAQ:RZLT) Short Interest Update - MarketBeat
Rezolute (NASDAQ:RZLT) Receives Buy Rating from HC Wainwright - MarketBeat
Rezolute Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
Rezolute Inc [RZLT] stock for 20,017 USD was acquired by Hogenhuis Wladimir - Knox Daily
Director Wladimir Hogenhuis Acquires 4,259 Shares of Rezolute In - GuruFocus.com
Affinity Asset Advisors LLC Acquires 250,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Affinity Asset Advisors LLC Purchases 250,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Rezolute executive Wladimir Hogenhuis buys $20,017 in company stock By Investing.com - Investing.com Australia
Rezolute, Inc. (NASDAQ:RZLT) Director Wladimir Hogenhuis Buys 4,259 Shares - Defense World
Rezolute executive Wladimir Hogenhuis buys $20,017 in company stock - Investing.com
US FDA lifts partial clinical hold on Rezolute's low blood sugar treatment - MSN
BTIG bullish on Rezolute stock as pivotal trials move forward and hold lifted - Investing.com Canada
Rezolute Inc [RZLT] Director makes an insider acquire of 4,815 shares worth 19,982. - Knox Daily
Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Misses Estimates By $0.14 EPS - Defense World
JMP Securities Reaffirms "Market Outperform" Rating for Rezolute (NASDAQ:RZLT) - MarketBeat
JMP Securities Reiterates “Market Outperform” Rating for Rezolute (NASDAQ:RZLT) - Defense World
Rezolute (NASDAQ:RZLT) Releases Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Rezolute Inc (RZLT) stock analysis: A simple moving average approach - US Post News
Upward Trajectory: Rezolute Inc (RZLT) Posts a Slidee, Closing at 4.82 - The Dwinnex
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update - ForexTV.com
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides ... - The Bakersfield Californian
Rezolve AI Pops on Microsoft Investment - Baystreet.ca
Renaissance Technologies LLC Increases Stake in Embraer S.A. (NYSE:ERJ) - Defense World
Realbotix CEO Purchases Additional Common Shares in Open Market - Business Wire
RegTech deals projected to drop by a third for 2024 as investors focus on larger deals - FinTech Global
Zebra Technologies to showcase end-to-end AI solutions at VISION 2024 - Tahawul Tech
Riding the Waves: A Guide to Investing in RELY Stock - The InvestChronicle
Recurly rebrands; new AI solutions - Advanced Television
Take off with The Real Brokerage Inc. (REAX): Get ready for trading - SETE News
Rezolve Ai Expands Customer Base with Three Key Partnerships for AI-Powered E-Commerce Platform - Vancity Buzz
Recurly Unveils Suite of AI-Driven Tools to Accelerate Subscriber Growth and Elevate Subscriber Experience - Silicon UK
Acadian Asset Management LLC Increases Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
The Real Brokerage Inc. (REAX) stock on the rise: An overview - US Post News
Rezolute Inc Stock (RZLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rezolute Inc Stock (RZLT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hogenhuis Wladimir | Director |
Jun 25 '24 |
Buy |
4.15 |
4,815 |
19,982 |
37,508 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Jun 14 '24 |
Buy |
3.91 |
4,300 |
16,828 |
54,352 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Jun 14 '24 |
Buy |
3.91 |
3,300 |
12,916 |
13,000 |
| Evans Daron | CFO |
Jun 14 '24 |
Buy |
4.04 |
40,000 |
161,568 |
40,000 |
| Evans Daron | CFO |
May 29 '24 |
Buy |
3.50 |
451 |
1,578 |
121,351 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
May 23 '24 |
Buy |
2.69 |
7,500 |
20,138 |
50,052 |
| Evans Daron | CFO |
May 24 '24 |
Buy |
3.23 |
2,942 |
9,503 |
13,000 |
| Evans Daron | CFO |
May 23 '24 |
Buy |
2.85 |
58 |
165 |
10,058 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Mar 28 '24 |
Buy |
2.55 |
500 |
1,275 |
1,076 |
| Evans Daron | CFO |
Mar 15 '24 |
Buy |
1.69 |
20,000 |
33,830 |
20,000 |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):